Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Oct 1;14(10):e087047.
doi: 10.1136/bmjopen-2024-087047.

Genicular artery embolisation versus sham embolisation for symptomatic osteoarthritis of the knee: a randomised controlled trial

Affiliations
Randomized Controlled Trial

Genicular artery embolisation versus sham embolisation for symptomatic osteoarthritis of the knee: a randomised controlled trial

Tijmen A van Zadelhoff et al. BMJ Open. .

Abstract

Objective: To determine the efficacy of genicular artery embolisation (GAE) compared with sham GAE for pain reduction in patients with symptomatic mild-to-moderate knee osteoarthritis (KOA).

Design: Double-blind randomised sham-controlled clinical trial conducted from June 2019 to December 2021. The follow-up period was 4 months.

Setting: Single-centre study conducted at a university medical centre in Rotterdam, Netherlands.

Participants: 58 adults with symptomatic mild-to-moderate KOA not improving with conservative treatment.

Interventions: Participants were randomised to receive either GAE treatment or a sham GAE treatment.

Main outcome measures: The primary outcome was reduction of pain measured with the Knee Injury and Osteoarthritis Outcome Score pain subscale (0-100, with 0 representing the worst pain outcome and 100 the best) after 4 months. Outcomes were assessed at baseline and 1 and 4 months.

Results: From June 2019 to December 2021, 58 patients were included. 29 patients were randomised to the GAE group and 29 to the sham group. All participants completed the study. The mean pain reduction after 4 months was 21.4 (95% CI 13.9 to 28.8) for the GAE group and 18.4 points (95% CI 11.6 to 25.1) for the sham group. The between-group difference for the mean pain reduction was 3.0 (95% CI -7.1 to 13.0) with an estimated Cohen's d effect size of d = 0.15 (95% CI -0.37 to 0.66). Group allocation was not a significant contributor to pain reduction (p = 0.31). No serious adverse events (AEs) occurred. 23 mild AEs occurred in the GAE group and 5 in the sham group.

Conclusion: We did not establish a clinical effect of GAE in patients with mild-to-moderate KOA as GAE produced a similar effect on pain reduction as a sham GAE procedure.

Trial registration number: NCT03884049.

Keywords: interventional radiology; knee; randomized controlled trial.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1. (A) Pre-embolisation angiography of the medial superior genicular artery of a right knee. Notice the blush appearance at the medial femoral condyle. (B) In the post-embolisation situation, the blush disappeared but the medial superior genicular artery is still open. This was considered a technically successful result.
Figure 2
Figure 2. A schematic depiction of all genicular arteries evaluated for a hyperaemic blush and how many times a specific artery was selected for embolisation (absolute number, proportion). (A) Superior patellar artery, (B) descending genicular artery, (C) lateral superior genicular artery, (D) medial superior genicular artery, (E) median genicular artery, (F) medial inferior genicular artery, (G) lateral inferior genicular artery and (H) anterior tibial recurrent artery.
Figure 3
Figure 3. Participant flow diagram. GAE, genicular artery embolisation; KL, Kellgren and Lawrence.

References

    1. Cross M, Smith E, Hoy D, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73:1323–30. doi: 10.1136/annrheumdis-2013-204763. - DOI - PubMed
    1. Cui A, Li H, Wang D, et al. Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. E Clin Med. 2020;29–30:100587. doi: 10.1016/j.eclinm.2020.100587. - DOI - PMC - PubMed
    1. McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthr Cartil. 2014;22:363–88. doi: 10.1016/j.joca.2014.01.003. - DOI - PubMed
    1. London NJ, Miller LE, Block JE. Clinical and economic consequences of the treatment gap in knee osteoarthritis management. Med Hypotheses. 2011;76:887–92. doi: 10.1016/j.mehy.2011.02.044. - DOI - PubMed
    1. Hermans J, Koopmanschap MA, Bierma-Zeinstra SMA, et al. Productivity costs and medical costs among working patients with knee osteoarthritis. Arthritis Care Res (Hoboken) 2012;64:853–61. doi: 10.1002/acr.21617. - DOI - PubMed

Publication types

Associated data

LinkOut - more resources